We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

Content type

Tags

Author

78 results found

Article

Borden Ladner Gervais LLP | Canada | 18 Oct 2017

Intellectual Property Weekly Abstracts Bulletin Week of October 16, 2017

The Federal Court recently issued the public decision in the reference on the patent infringement finding and the section 8 damages finding between

Article

Borden Ladner Gervais LLP | USA, Canada | 16 Oct 2017

Intellectual Property Weekly Abstracts Bulletin Week of October 9, 2017

The Federal Court recently issued the public decision in the reference on the patent infringement finding and the section 8 damages finding between

Article

Borden Ladner Gervais LLP | Canada | 31 May 2017

Apotex's claims against current and former Ministers and civil servants working at the Ministry of Health is not struck for a lack of jurisdiction

The Federal Court has refused to strike a claim brought by Apotex against current and former ministers and civil servants working at the Ministry of

Article

Borden Ladner Gervais LLP | Canada | 10 May 2017

Reasonable Royalty and Accounting of Profits Determinations Made

In a previous decision, which was affirmed, the Court found that Dow's patent was valid and infringed by Nova. Once a finding of liability was made

Article

Borden Ladner Gervais LLP | Canada | 10 May 2017

Court Refuses Motion to Amend Brought After the Commencement of the Quantification Trial

This decision concerned the quantification phase following the liability determination, which found AstraZeneca's patent valid and infringed. Apotex

Article

Borden Ladner Gervais LLP | Canada | 19 Apr 2017

Court of Appeal Grants Appeal as it Relates to Duty to Mitigate

In this decision, the Court of Appeal was considering an appeal by Apotex of various findings of the Court relating to its action seeking damages from

Article

Borden Ladner Gervais LLP | Canada | 19 Apr 2017

Court of Appeal Dismisses Appeal for Different Reasons and Provides Review of the Obvious to Try Test

The Court of Appeal dismissed Bristol-Myers Squibb's appeal from the Trial Judge's decision refusing its application for a writ of prohibition on the

Article

Borden Ladner Gervais LLP | Canada | 12 Apr 2017

Apotex Granted Leave to Expand Scope of Evidence Available to Prove its NIA Plea

In this recently reported decision, the Court granted Apotex leave to deliver Fresh as Amended Responding Statement of Issues for the reference into

Article

Borden Ladner Gervais LLP | Canada | 6 Apr 2017

Order of prohibition dismissed in respect of two patents listed against dasatinib

The Court dismissed Bristol Myers Squibb's application for an order prohibiting the Minister from issuing an NOC to Apotex for its generic version of

Article

Borden Ladner Gervais LLP | Canada | 6 Apr 2017

Court dismisses JR of Minister's decision requiring additional information for approval of certain products manufactured or tested at two of Apotex's manufacturing facilities

The Court dismissed Apotex's application for judicial review, finding that Therapeutic Products Directorate of Health Canada's ("TPD") decision

Previous page 1 2 3 ...